TNP-470 is an effective antimicrosporidial agent

Christina Coyle, Michael Kent, Herbert B. Tanowitz, Murray Wittner, Louis M. Weiss

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Therapy for microsporidia, which cause diarrhea and a wasting syndrome in persons with AIDS, has had limited success. Fumagillin, a naturally secreted water-insoluble antibiotic, has in vitro activity against microsporidia and has been used successfully in the treatment of superficial keratitis in patients with AIDS, but systemic therapy has been limited by toxicity of the currently available fumagillin salt. TNP-470, a semisynthetic analogue of fumagillin, was studied in vitro and in the athymic nude mouse model of microsporidiosis. RK13 cells were infected with microsporidia of the family Encephalitozoonidae and treated at day 3 with TNP-470. This agent was highly effective, with an ID50 (50% inhibitory dose compared with control) of 0.001 μg/mL. TNP-470 also demonstrated in vivo activity against Encephalitozoon cuniculi, with prolonged survival and the prevention of the development of ascites in infected athymic mice. These data suggest that the fumagillin derivative TNP-470 is a promising agent for the treatment of microsporidiosis.

Original languageEnglish (US)
Pages (from-to)515-518
Number of pages4
JournalJournal of Infectious Diseases
Volume177
Issue number2
StatePublished - 1998

Fingerprint

Microsporidia
Microsporidiosis
Nude Mice
Acquired Immunodeficiency Syndrome
Encephalitozoon cuniculi
Wasting Syndrome
Keratitis
Therapeutics
Ascites
Diarrhea
Salts
Anti-Bacterial Agents
Survival
O-(chloroacetylcarbamoyl)fumagillol
fumagillin
Water
In Vitro Techniques

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Coyle, C., Kent, M., Tanowitz, H. B., Wittner, M., & Weiss, L. M. (1998). TNP-470 is an effective antimicrosporidial agent. Journal of Infectious Diseases, 177(2), 515-518.

TNP-470 is an effective antimicrosporidial agent. / Coyle, Christina; Kent, Michael; Tanowitz, Herbert B.; Wittner, Murray; Weiss, Louis M.

In: Journal of Infectious Diseases, Vol. 177, No. 2, 1998, p. 515-518.

Research output: Contribution to journalArticle

Coyle, C, Kent, M, Tanowitz, HB, Wittner, M & Weiss, LM 1998, 'TNP-470 is an effective antimicrosporidial agent', Journal of Infectious Diseases, vol. 177, no. 2, pp. 515-518.
Coyle, Christina ; Kent, Michael ; Tanowitz, Herbert B. ; Wittner, Murray ; Weiss, Louis M. / TNP-470 is an effective antimicrosporidial agent. In: Journal of Infectious Diseases. 1998 ; Vol. 177, No. 2. pp. 515-518.
@article{245e9fdff7fc4c3f97a664b8a7c12c1d,
title = "TNP-470 is an effective antimicrosporidial agent",
abstract = "Therapy for microsporidia, which cause diarrhea and a wasting syndrome in persons with AIDS, has had limited success. Fumagillin, a naturally secreted water-insoluble antibiotic, has in vitro activity against microsporidia and has been used successfully in the treatment of superficial keratitis in patients with AIDS, but systemic therapy has been limited by toxicity of the currently available fumagillin salt. TNP-470, a semisynthetic analogue of fumagillin, was studied in vitro and in the athymic nude mouse model of microsporidiosis. RK13 cells were infected with microsporidia of the family Encephalitozoonidae and treated at day 3 with TNP-470. This agent was highly effective, with an ID50 (50{\%} inhibitory dose compared with control) of 0.001 μg/mL. TNP-470 also demonstrated in vivo activity against Encephalitozoon cuniculi, with prolonged survival and the prevention of the development of ascites in infected athymic mice. These data suggest that the fumagillin derivative TNP-470 is a promising agent for the treatment of microsporidiosis.",
author = "Christina Coyle and Michael Kent and Tanowitz, {Herbert B.} and Murray Wittner and Weiss, {Louis M.}",
year = "1998",
language = "English (US)",
volume = "177",
pages = "515--518",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - TNP-470 is an effective antimicrosporidial agent

AU - Coyle, Christina

AU - Kent, Michael

AU - Tanowitz, Herbert B.

AU - Wittner, Murray

AU - Weiss, Louis M.

PY - 1998

Y1 - 1998

N2 - Therapy for microsporidia, which cause diarrhea and a wasting syndrome in persons with AIDS, has had limited success. Fumagillin, a naturally secreted water-insoluble antibiotic, has in vitro activity against microsporidia and has been used successfully in the treatment of superficial keratitis in patients with AIDS, but systemic therapy has been limited by toxicity of the currently available fumagillin salt. TNP-470, a semisynthetic analogue of fumagillin, was studied in vitro and in the athymic nude mouse model of microsporidiosis. RK13 cells were infected with microsporidia of the family Encephalitozoonidae and treated at day 3 with TNP-470. This agent was highly effective, with an ID50 (50% inhibitory dose compared with control) of 0.001 μg/mL. TNP-470 also demonstrated in vivo activity against Encephalitozoon cuniculi, with prolonged survival and the prevention of the development of ascites in infected athymic mice. These data suggest that the fumagillin derivative TNP-470 is a promising agent for the treatment of microsporidiosis.

AB - Therapy for microsporidia, which cause diarrhea and a wasting syndrome in persons with AIDS, has had limited success. Fumagillin, a naturally secreted water-insoluble antibiotic, has in vitro activity against microsporidia and has been used successfully in the treatment of superficial keratitis in patients with AIDS, but systemic therapy has been limited by toxicity of the currently available fumagillin salt. TNP-470, a semisynthetic analogue of fumagillin, was studied in vitro and in the athymic nude mouse model of microsporidiosis. RK13 cells were infected with microsporidia of the family Encephalitozoonidae and treated at day 3 with TNP-470. This agent was highly effective, with an ID50 (50% inhibitory dose compared with control) of 0.001 μg/mL. TNP-470 also demonstrated in vivo activity against Encephalitozoon cuniculi, with prolonged survival and the prevention of the development of ascites in infected athymic mice. These data suggest that the fumagillin derivative TNP-470 is a promising agent for the treatment of microsporidiosis.

UR - http://www.scopus.com/inward/record.url?scp=0031929734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031929734&partnerID=8YFLogxK

M3 - Article

C2 - 9466552

AN - SCOPUS:0031929734

VL - 177

SP - 515

EP - 518

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 2

ER -